These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28504856)

  • 1. Cell-free DNA copy number variations in plasma from colorectal cancer patients.
    Li J; Dittmar RL; Xia S; Zhang H; Du M; Huang CC; Druliner BR; Boardman L; Wang L
    Mol Oncol; 2017 Aug; 11(8):1099-1111. PubMed ID: 28504856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
    Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
    Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier.
    Yu D; Liu Z; Su C; Han Y; Duan X; Zhang R; Liu X; Yang Y; Xu S
    Thorac Cancer; 2020 Jan; 11(1):95-102. PubMed ID: 31694073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma.
    Xu JF; Kang Q; Ma XY; Pan YM; Yang L; Jin P; Wang X; Li CG; Chen XC; Wu C; Jiao SZ; Sheng JQ
    Cell Physiol Biochem; 2018; 45(4):1444-1454. PubMed ID: 29466793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments.
    Wang Y; Zhou K; Wang X; Liu Y; Guo D; Bian Z; Su L; Liu K; Gu X; Guo X; Wang L; Zhang H; Tao K; Xing J
    Cancer Sci; 2021 Nov; 112(11):4772-4784. PubMed ID: 34490703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma HER2 (
    Siravegna G; Sartore-Bianchi A; Nagy RJ; Raghav K; Odegaard JI; Lanman RB; Trusolino L; Marsoni S; Siena S; Bardelli A
    Clin Cancer Res; 2019 May; 25(10):3046-3053. PubMed ID: 30808777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort.
    Chen X; Chang CW; Spoerke JM; Yoh KE; Kapoor V; Baudo C; Aimi J; Yu M; Liang-Chu MMY; Suttmann R; Huw LY; Gendreau S; Cummings C; Lackner MR
    Clin Cancer Res; 2019 Apr; 25(7):2254-2263. PubMed ID: 30617129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.
    Xia S; Kohli M; Du M; Dittmar RL; Lee A; Nandy D; Yuan T; Guo Y; Wang Y; Tschannen MR; Worthey E; Jacob H; See W; Kilari D; Wang X; Hovey RL; Huang CC; Wang L
    Oncotarget; 2015 Jun; 6(18):16411-21. PubMed ID: 25915538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
    Oh CR; Kong SY; Im HS; Kim HJ; Kim MK; Yoon KA; Cho EH; Jang JH; Lee J; Kang J; Park SR; Ryoo BY
    BMC Cancer; 2019 Apr; 19(1):292. PubMed ID: 30935424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
    Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
    Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy.
    Weiss GJ; Beck J; Braun DP; Bornemann-Kolatzki K; Barilla H; Cubello R; Quan W; Sangal A; Khemka V; Waypa J; Mitchell WM; Urnovitz H; Schütz E
    Clin Cancer Res; 2017 Sep; 23(17):5074-5081. PubMed ID: 28320758
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.
    Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M
    Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.
    Molparia B; Oliveira G; Wagner JL; Spencer EG; Torkamani A
    PLoS One; 2018; 13(5):e0196826. PubMed ID: 29791457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers.
    Yang X; Hu Y; Yang K; Wang D; Lin J; Long J; Xie F; Mao J; Bian J; Guan M; Pan J; Huo L; Hu K; Yang X; Mao Y; Sang X; Zhang J; Wang X; Zhang H; Zhao H
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33972389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
    Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
    Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
    Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.